Tylosin

Tylosin is a lipid of Polyketides (PK) class. Tylosin is associated with abnormalities such as Mastitis, Bovine, Infection, Bacterial Infections, Arthritis and Ileitis. The involved functions are known as Anabolism, acireductone dioxygenase [iron(II)-requiring] activity, Protein Biosynthesis, Mastitis and Methylation. Tylosin often locates in Ribosomes, Cell Wall, 50S ribosomal subunit, Ribosome Subunits, Large and Ribosome Subunits. The associated genes with Tylosin are Gene Clusters, Genome, resistance genes, Homologous Gene and HM13 gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Tylosin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tylosin?

Tylosin is suspected in Porcine ulcerative spirochetosis, Infection, Liver Abscess, Respiration Disorders, Intestinal Diseases, Mastitis, Bovine and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tylosin

MeSH term MeSH ID Detail
Digital Dermatitis D058066 3 associated lipids
Bovine Respiratory Disease Complex D048090 2 associated lipids
Pneumonia of Calves, Enzootic D048089 2 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Pneumonia of Swine, Mycoplasmal D045729 2 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Primate Diseases D018419 2 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Per page 10 20 50 | Total 47

PubChem Associated disorders and diseases

What pathways are associated with Tylosin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tylosin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tylosin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tylosin?

There are no associated biomedical information in the current reference collection.

What genes are associated with Tylosin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tylosin?

Knock-out

Knock-out are used in the study 'A second tylosin resistance determinant, Erm B, in Arcanobacterium pyogenes.' (Jost BH et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tylosin

Download all related citations
Per page 10 20 50 100 | Total 931
Authors Title Published Journal PubMed Link
Whitehead TR and Cotta MA Stored swine manure and swine faeces as reservoirs of antibiotic resistance genes. 2013 Lett. Appl. Microbiol. pmid:23297734
Mathieson PW et al. Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. 1992 Lab. Invest. pmid:1625442
Modric S et al. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats. 1999 Lab. Anim. Sci. pmid:10403438
Diagnosis | pasteurellosis. 2008 Lab Anim (NY) pmid:18094697
Takahashi I et al. [In vitro resistance acquisition in Mycoplasma gallisepticum against ofloxacin, tylosin and spectinomycin]. 2002 Jpn J Antibiot pmid:12199113
Neiffer DL Clostridium perfringens enterotoxicosis in two Amur leopards (Panthera pardus orientalis). 2001 J. Zoo Wildl. Med. pmid:12790411
Simpson EJ et al. A simple method for the removal of mycoplasma contamination from paramyxovirus stocks. 1983 J. Virol. Methods pmid:6190834
Coronato S et al. A simple method to eliminate mycoplasma from cell cultures. 1994 J. Virol. Methods pmid:8175949
Lee SW et al. Prevalence of porcine proliferative enteropathy and its control with tylosin in Korea. 2001 J. Vet. Sci. pmid:12441690
Hwang YH et al. Simultaneous determination of various macrolides by liquid chromatography/mass spectrometry. 2002 J. Vet. Sci. pmid:12441679
Kim D et al. In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin. 2006 J. Vet. Sci. pmid:17106227
Zhang L et al. Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with . 2017 J. Vet. Sci. pmid:28385011
Clark C et al. Pharmacokinetics of tilmicosin in equine tissues and plasma. 2008 J. Vet. Pharmacol. Ther. pmid:18177321
Christodoulopoulos G et al. Tilmicosin administration to young lambs with respiratory infection: safety and efficacy considerations. 2002 J. Vet. Pharmacol. Ther. pmid:12423233
Fajt VR et al. The effects of danofloxacin and tilmicosin on neutrophil function and lung consolidation in beef heifer calves with induced Pasteurella (Mannheimia) haemolytica pneumonia. 2003 J. Vet. Pharmacol. Ther. pmid:12755900
Elitok B and Elitok OM Clinical efficacy of carprofen as an adjunct to the antibacterial treatment of bovine respiratory disease. 2004 J. Vet. Pharmacol. Ther. pmid:15500569
Clark C et al. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum. 2004 J. Vet. Pharmacol. Ther. pmid:15500580
Jordan FT et al. A comparison of the efficacy of danofloxacin and tylosin in the control of Mycoplasma gallisepticum infection in broiler chicks. 1993 J. Vet. Pharmacol. Ther. pmid:8386777
Fajt VR et al. Effects of danofloxacin and tilmicosin on circulating neutrophils in beef heifers. 2000 J. Vet. Pharmacol. Ther. pmid:11110107
Ziv G et al. Disposition kinetics of tylosin tartrate administered intravenously and intramuscularly to normal and water-deprived camels. 1995 J. Vet. Pharmacol. Ther. pmid:8583543
Ziv G et al. Tilmicosin antibacterial activity and pharmacokinetics in cows. 1995 J. Vet. Pharmacol. Ther. pmid:8587151
Brown SA et al. Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice. 1995 J. Vet. Pharmacol. Ther. pmid:8587160
Main BW et al. Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs. 1996 J. Vet. Pharmacol. Ther. pmid:8803881
Dieste-Pérez L et al. Studies on a suitable antibiotic therapy for treating swine brucellosis. 2015 J. Vet. Pharmacol. Ther. pmid:25413993
Womble A et al. Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens. 2006 J. Vet. Pharmacol. Ther. pmid:17083461
Canning P et al. Concentrations of tylvalosin and 3-O-acetyltylosin attained in the synovial fluid of swine after administration by oral gavage at 50 and 5 mg/kg. 2016 J. Vet. Pharmacol. Ther. pmid:27086612
Ling Z et al. Preparation, characterization, and pharmacokinetics of tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles. 2017 J. Vet. Pharmacol. Ther. pmid:27687707
Torres F et al. Pharmacokinetics of tildipirosin in pig tonsils. 2016 J. Vet. Pharmacol. Ther. pmid:26935349
Rose M et al. A microbiological assay to estimate the antimicrobial activity of parenteral tildipirosin against foodborne pathogens and commensals in the colon of beef cattle and pigs. 2016 J. Vet. Pharmacol. Ther. pmid:26538405
Menge M et al. Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle). 2012 J. Vet. Pharmacol. Ther. pmid:22188102
Canning P et al. Variation in water disappearance, daily dose, and synovial fluid concentrations of tylvalosin and 3-O-acetyltylosin in commerical pigs during five day water medication with tylvalosin under field conditions. 2018 J. Vet. Pharmacol. Ther. pmid:29572923
Rose M et al. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae. 2013 J. Vet. Pharmacol. Ther. pmid:22500881
Ling Z et al. Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics. 2018 J. Vet. Pharmacol. Ther. pmid:29139136
Wang J et al. Pharmacokinetics of tildipirosin in beagle dogs. 2018 J. Vet. Pharmacol. Ther. pmid:28892155
Ji LW et al. Comparative pharmacokinetics and bioavailability of tylosin tartrate and tylosin phosphate after a single oral and i.v. administration in chickens. 2014 J. Vet. Pharmacol. Ther. pmid:24325541
Mohammadsadegh M Impact of intramammary tilmicosin infusion as a dry cow therapy. 2018 J. Vet. Pharmacol. Ther. pmid:28600854
Han C et al. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies. 2009 J. Vet. Pharmacol. Ther. pmid:19290940
Catry B et al. Efficacy of metaphylactic florfenicol therapy during natural outbreaks of bovine respiratory disease. 2008 J. Vet. Pharmacol. Ther. pmid:19000268
Fricke JA et al. Pharmacokinetics and tissue depletion of tilmicosin in turkeys. 2008 J. Vet. Pharmacol. Ther. pmid:19000285
Scorneaux B and Shryock TR Intracellular accumulation, subcellular distribution and efflux of tilmicosin in swine phagocytes. 1998 J. Vet. Pharmacol. Ther. pmid:9731947
Scorneaux B and Shryock TR The determination of the cellular volume of avian, porcine and bovine phagocytes and bovine mammary epithelial cells and its relationship to uptake of tilmicosin. 1999 J. Vet. Pharmacol. Ther. pmid:10211711
Cerdá RO et al. Impact of the type of catheter on the absorption of tylvalosin (acetylvaleryltylosin) administered orally to broiler chickens. 2010 J. Vet. Pharmacol. Ther. pmid:20444046
Lombardi KR et al. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration. 2011 J. Vet. Pharmacol. Ther. pmid:21323676
Modric S et al. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. 1998 J. Vet. Pharmacol. Ther. pmid:9885967
Thomas E et al. A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease. 2001 J. Vet. Pharmacol. Ther. pmid:11696086
Foster DM et al. Comparison of direct sampling and brochoalveolar lavage for determining active drug concentrations in the pulmonary epithelial lining fluid of calves injected with enrofloxacin or tilmicosin. 2017 J. Vet. Pharmacol. Ther. pmid:28457009
Prapasarakul N et al. In vitro susceptibility and a new point mutation associated with tylosin-resistance in Japanese canine intestinal spirochetes. 2003 J. Vet. Med. Sci. pmid:14709813
Kim EY et al. Pharmacokinetics of a florfenicol-tylosin combination after intravenous and intramuscular administration to beagle dogs. 2011 J. Vet. Med. Sci. pmid:21068517
Katoh T et al. Effect of a combination of antimicrobial agents for the treatment of respiratory disease in cattle. 1996 J. Vet. Med. Sci. pmid:8877980
Kobayashi H et al. In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents. 1996 J. Vet. Med. Sci. pmid:8959659